Enjoy complimentary customisation on priority with our Enterprise License!
The global enteral syringe market size is estimated to grow by USD 411.85 million at a CAGR of 5.7% between 2022 and 2027.
The prevalence of home enteral nutrition is increasing worldwide. According to the National Institute of Health (NIH), the prevalence of home enteral nutrition is increasing. Factors such as the aging population, increasing incidence of chronic conditions, and growing preference for treatment in the home care setting are contributing to the increasing prevalence of home enteral nutrition. Additionally, due to the persistent cost pressure in the hospital sector, the preference for treatment in the home care setting has increased, which has further increased the demand for home enteral nutrition. Thus, the growing demand for home enteral nutrition will contribute to the growth of the global enteral syringe market during the forecast period.
Technavio has segmented the market into Product, Application, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The market share growth by the disposable syringes segment will be significant during the forecast period. Increased number of product launches from leading market players, updated regulatory guidelines for enteral device manufacturing to ensure safe enteral feeding, and the choice of disposable syringes over reusable syringes due to growing concerns about patient infection are the key factors driving the growth of disposable syringes segment.
Get a glance at the market contribution of various segments View a PDF Sample
The disposable syringes segment was valued at USD 648.30 million in 2017. The demand for enteral syringes is rising due to an increase in preterm births and a growing elderly population. Government agencies promote the use of disposable syringes for enteral feeding to avoid the risk of infection. For example, organizations such as the American Society for Parenteral Nutrition (ASPEN) and the Human Milk Banking Association of North America (HMBANA) have set guidelines for the implementation of disposable syringes. Such policies of governments and healthcare institutions are likely to boost the adoption of disposable syringes and will drive the growth of the market during the forecast period.
Elderly people are more susceptible to infections and age-related illnesses. Age-related changes in muscle mass and body composition, as well as comorbidities (stroke, dementia, depression), contribute to malnutrition and frailty in elderly patients. Therefore, enteral nutrition is required for older adults diagnosed with chronic diseases such as severe neurological dysphagia. Other factors, such as increased efforts by government agencies and the establishment of regulatory guidelines for the manufacture of safe enteral syringes, are expected to increase the acceptance of enteral syringes among adults during the forecast period.
Neonatal and pediatric enteral syringes are medical devices used to feed newborns who cannot take food by mouth and cannot safely swallow, or who require nutritional supplementation. The increase in preterm births leading to neonatal hospitalization is a major factor in increasing the demand for neonatal and pediatric enteral syringes. Asian countries such as Pakistan, Indonesia, the Philippines, and Bangladesh have a high prevalence of preterm birth. Therefore, the rise in the number of preterm and low birth weight infants will increase the demand for enteral nutrition, which is expected to drive the growth of the neonatal and pediatric segment of the global enteral syringe market during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The rising prevalence of chronic conditions such as neurological disorders and cancer is driving the demand for enteral syringes. The advantageous reimbursement for enteral feeding is probable to drive the growth of the regional enteral syringe market.
Moreover, government and non-profit organizations in the region are developing awareness programs about enteral feeding, which will drive the growth of the enteral syringe market. The US FDA recommends hospitals and clinicians use enteral devices with connectors that meet the ISO 80369-1 or ISO 80369-3 standard or that are designed to reduce the risk of misconnections. Such initiatives from government organizations regarding the safety of enteral feeding syringes will increase the adoption of enteral syringes during the forecast period.
The growth of the enteral syringe market in North America was negatively impacted due to the outbreak of COVID-19 in 2020. However, in 2021, the initiation of large-scale vaccination drives?lifted the lockdown and travel restrictions. Hospitals started resuming elective procedures, leading to a resurgence in demand for enteral syringes. Additionally, patients and healthcare providers are increasingly embracing the concept of managing their medical needs at home, resulting in increased demand for home enteral syringes. Thus, such factors are expected to increase the demand for enteral syringes, which is expected to drive the growth of the regional enteral syringes market during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Medela AG: The company offers enteral syringe products such as Medela Syringes with ENFit connectors, a multi functional syringe design that can be used for pump feeds, closed gravity feeding, and venting.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The increasing prevalence of chronic conditions is the key factor driving the growth of the market. The prevalence of oral cancer is growing across the globe. Oral cancer develops on the tongue, oral mucosa, mouth, and oropharynx (area of the throat at the back of the mouth). The key factors attributed to the growth of oral cancer are smoking and frequent consumption of alcohol.
Moreover, nasopharyngeal cancer cases account for 3% of all new cancer cases in the US each year, with the global nasopharyngeal cancer treatment market increasing in the past few years. Therefore, the increasing number of chronic diseases is expected to drive the growth of the global enteral syringe market during the forecast period.
Increasing awareness about enteral feeding in critical care conditions is the primary trend in the market. Non-profit organizations and product manufacturers organize awareness campaigns about the safety of enteral feeding for infants and adults. For example, the Feeding Tube Awareness Foundation is a non-profit organization founded and run by parents of children who support tube feeding. The organization raises awareness among parents and caregivers about enteral feeding as a positive life-saving medical procedure.
Moreover, product manufacturers raise awareness and organize courses to educate medical professionals about new technologies and safety measures during enteral feeding. Thus, such awareness and educational campaigns about enteral nutrition and new enteral devices will encourage the adoption of enteral nutrition, which will increase the growth of the enteral syringe market during the forecast period.
The lack of skilled nurses and advanced infrastructure in developing countries is a challenge that affects the growth of the market. Lack of qualified and trained professionals in health care systems, especially in developing countries, is a major factor limiting the use of enteral syringes, impacting sales of enteral syringes. Healthcare systems in developing countries lack sufficient resources. Developing countries such as South Africa, Colombia, Turkey, and Mexico have a shortage of qualified nursing staff.
Additionally, medical infrastructure in developing countries lacks advanced technology and equipment. The main reason for poor health infrastructure in developing countries is the lack of investment by government agencies in improving health facilities. Therefore, the lack of qualified and trained nurses in developing countries, poor healthcare infrastructure, and lack of awareness of advanced technologies will hinder the growth of the global enteral syringe market during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Enteral Syringe Market Customer Landscape
The enteral syringe market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Enteral Syringe Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.7% |
Market growth 2023-2027 |
USD 411.85 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.24 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 34% |
Key countries |
US, Germany, UK, China, and India |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Amsino International Inc., Andway Healthcare Ltd., Avanos Medical Inc, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Cardinal Health Inc., Danone SA, DMC Medical Ltd., GBUK Group Ltd, Jiangsu Caina Medical Co. Ltd., Micsafe Medical Group, Kentec Medical Inc., Medela AG, Medicina Ltd., Medline Industries LP, Miktell Ltd., Terumo Corp., Thermo Fisher Scientific Inc., and Vygon SAS |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. You may change your settings based on a legitimate interest at any time, by selecting “Manage Settings” on our site. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.